Latest Health News
WHO closes Second Global Summit on Traditional Medicine with new strategy
WHO announced integration of safe, evidence‑informed traditional medicine into health systems and launched the WHO Global Traditional Medicine Strategy 2025–2034 at the Summit closing remarks in India.
WHO/PAHO report highlights regional health gains and emergencies response in the Americas
PAHO summarized 2025 progress supporting countries in disease elimination, emergency response and health self‑reliance across the Americas, noting both challenges and encouraging results.
WHO issues first global guideline supporting GLP‑1 use for obesity management
WHO published guidance recognizing GLP‑1 receptor agonists as an option for long‑term obesity treatment after trials showed substantial weight loss and cardiometabolic benefits.
Powerful obesity medicines prompt research into neurological uses
Researchers reported multiple trials (six published by Dec 2025) exploring GLP‑1 drugs in Parkinson’s and other neurologic diseases; results so far are mixed and under active study.
Respiratory virus rates climbing ahead of winter 2025–26 in the U.S.
Johns Hopkins public‑health experts reported rising respiratory virus transmission in the U.S. heading into winter 2025–26, raising concerns for healthcare demand during the holidays.
Major medical and biotech breakthroughs spotlighted in 2025
Reviews of 2025 medical advances highlighted custom gene editing for a child, stem‑cell heart patches in primates, organ‑regeneration discoveries, and a billion+ imaging measurements from UK Biobank aiding disease mapping.
UCLA performs world’s first successful human bladder transplant
UCLA reported the first successful human bladder transplant combined with kidney transplantation, an eight‑hour operation offering new options for severe bladder dysfunction.
Nobel Prize recognition fuels immunology and Treg research advances
Coverage of 2025 milestones noted Nobel recognition for discoveries in regulatory T cells (Tregs), accelerating therapies for autoimmune disease, transplantation, and cancer.
EU publishes 'Safe Hearts' Plan for cardiovascular prevention across member states
The European Commission released the EU Safe Hearts Plan, a comprehensive EU‑wide strategy dedicated to cardiovascular health and prevention launched in mid‑December 2025.
Gilead and U.S. government agreement on medicine pricing
Gilead announced an agreement with the U.S. government to lower medicine costs addressing presidential requests to reduce drug prices while protecting biopharma leadership.
Advances in gene therapy show durable protection for children with rare immune disorders
UCLA‑linked gene therapy reported durable immune restoration in children with ADA‑SCID, with 59 of 62 treated remaining healthy and free of serious complications in follow‑up reports.
Predictive models and microbiome research aim to prevent C. difficile infections
Institute for Systems Biology researchers developed personalized modeling frameworks to predict and potentially prevent C. difficile colonization, suggesting targeted probiotic strategies.
FDA clears enhancements to Omnipod 5 automated insulin delivery system
Insulet received FDA 510(k) clearance for significant Omnipod 5 updates, including a lower 100 mg/dL target glucose option to improve automated diabetes management.
US policy emphasizes 'America‑first' global health strategy
U.S. policy discussions in 2025 included an 'America‑First Global Health Strategy' advocating investments abroad that also benefit domestic health security, per analysis of U.S. government direction.
Research institutions publish 2025 health research roundups showing translational progress
Institutions including Van Andel Institute and ISB summarized 2025 breakthroughs—epigenetic single‑cell techniques, cancer immune strategies, and predictive models for infection and cancer risk—highlighting translational potential.